Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sagent Pharmaceuticals Inc (NASDAQ:SGNT)

During the Trading Day
13.34 -0.69 / -4.92%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
13.34 +0.0027 / +0.02%
Volume: 11.9K
Health Technology
Pharmaceuticals: Other

Company Description

Sagent Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products. With a primary focus on generic injectable pharmaceuticals, the company offers its customers a broad range of products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes and premix bags. Sagent Pharmaceuticals was founded by Jeffrey M. Yordon on January 26, 2006 and is headquartered in Schaumburg, IL.

Contact Information

Sagent Pharmaceuticals, Inc.
1901 North Roselle Road
Schaumburg Illinois 60195
P:(847) 908-1600
Investor Relations:
(847) 908-1605



Individual stakeholders53.44%
Other institutional45.77%
Mutual fund holders39.31%

Top Executives

Allan ObermanChief Executive Officer & Director
Michael LogerfoPresident, Secretary & Chief Legal Officer
Jonathon M. SingerChief Financial Officer & Executive Vice President
Jeffrey W. GreveVice President & Controller
Lorin DrakeVice President-Sales